Logo image of SPCB

SUPERCOM LTD (SPCB) Stock Fundamental Analysis

NASDAQ:SPCB - Nasdaq - IL0010830961 - Common Stock - Currency: USD

10.52  +0.03 (+0.29%)

After market: 10.42 -0.1 (-0.95%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SPCB. SPCB was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. While SPCB seems to be doing ok healthwise, there are quite some concerns on its profitability. SPCB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SPCB was profitable.
In the past 5 years SPCB reported 4 times negative net income.
In the past 5 years SPCB always reported negative operating cash flow.
SPCB Yearly Net Income VS EBIT VS OCF VS FCFSPCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of SPCB (1.04%) is comparable to the rest of the industry.
SPCB's Return On Equity of 1.90% is in line compared to the rest of the industry. SPCB outperforms 56.00% of its industry peers.
Industry RankSector Rank
ROA 1.04%
ROE 1.9%
ROIC N/A
ROA(3y)-8.43%
ROA(5y)-13.77%
ROE(3y)-105.34%
ROE(5y)-141.36%
ROIC(3y)N/A
ROIC(5y)N/A
SPCB Yearly ROA, ROE, ROICSPCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

With a decent Profit Margin value of 2.39%, SPCB is doing good in the industry, outperforming 64.00% of the companies in the same industry.
SPCB has a Gross Margin of 48.43%. This is amongst the best in the industry. SPCB outperforms 84.00% of its industry peers.
In the last couple of years the Gross Margin of SPCB has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 2.39%
GM 48.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5Y4.68%
SPCB Yearly Profit, Operating, Gross MarginsSPCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

SPCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SPCB has been increased compared to 1 year ago.
SPCB has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SPCB has an improved debt to assets ratio.
SPCB Yearly Shares OutstandingSPCB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
SPCB Yearly Total Debt VS Total AssetsSPCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

SPCB has an Altman-Z score of -0.22. This is a bad value and indicates that SPCB is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.22, SPCB is not doing good in the industry: 79.20% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.71 indicates that SPCB is somewhat dependend on debt financing.
SPCB has a worse Debt to Equity ratio (0.71) than 84.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -0.22
ROIC/WACCN/A
WACC6.95%
SPCB Yearly LT Debt VS Equity VS FCFSPCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

SPCB has a Current Ratio of 9.69. This indicates that SPCB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 9.69, SPCB belongs to the top of the industry, outperforming 90.40% of the companies in the same industry.
SPCB has a Quick Ratio of 9.06. This indicates that SPCB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 9.06, SPCB belongs to the best of the industry, outperforming 92.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.69
Quick Ratio 9.06
SPCB Yearly Current Assets VS Current LiabilitesSPCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.19% over the past year.
Looking at the last year, SPCB shows a small growth in Revenue. The Revenue has grown by 4.01% in the last year.
Measured over the past years, SPCB shows a quite strong growth in Revenue. The Revenue has been growing by 10.90% on average per year.
EPS 1Y (TTM)103.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
Revenue 1Y (TTM)4.01%
Revenue growth 3Y31.09%
Revenue growth 5Y10.9%
Sales Q2Q%2.89%

3.2 Future

SPCB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.66% yearly.
The Revenue is expected to grow by 12.66% on average over the next years. This is quite good.
EPS Next Y190.92%
EPS Next 2Y-0.44%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue Next Year0.17%
Revenue Next 2Y10.94%
Revenue Next 3Y12.66%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SPCB Yearly Revenue VS EstimatesSPCB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
SPCB Yearly EPS VS EstimatesSPCB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 100 150 200

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.46, the valuation of SPCB can be described as very cheap.
Based on the Price/Earnings ratio, SPCB is valued cheaper than 96.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, SPCB is valued rather cheaply.
The Price/Forward Earnings ratio is 14.95, which indicates a correct valuation of SPCB.
85.60% of the companies in the same industry are more expensive than SPCB, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, SPCB is valued a bit cheaper.
Industry RankSector Rank
PE 7.46
Fwd PE 14.95
SPCB Price Earnings VS Forward Price EarningsSPCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SPCB indicates a somewhat cheap valuation: SPCB is cheaper than 60.80% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.2
SPCB Per share dataSPCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y-0.44%
EPS Next 3Y0.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SPCB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUPERCOM LTD

NASDAQ:SPCB (7/11/2025, 8:00:02 PM)

After market: 10.42 -0.1 (-0.95%)

10.52

+0.03 (+0.29%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-13 2025-08-13
Inst Owners12.62%
Inst Owner Change0%
Ins Owners4.78%
Ins Owner ChangeN/A
Market Cap43.13M
Analysts82.5
Price Target14.28 (35.74%)
Short Float %4.83%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)849.78%
Min EPS beat(2)-130.55%
Max EPS beat(2)1830.1%
EPS beat(4)2
Avg EPS beat(4)442.19%
Min EPS beat(4)-226.87%
Max EPS beat(4)1830.1%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.94%
Min Revenue beat(2)-4.3%
Max Revenue beat(2)-1.59%
Revenue beat(4)1
Avg Revenue beat(4)3.9%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)23.28%
Revenue beat(8)5
Avg Revenue beat(8)18.01%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-22.22%
EPS NQ rev (1m)987.5%
EPS NQ rev (3m)987.5%
EPS NY rev (1m)4150%
EPS NY rev (3m)5162.5%
Revenue NQ rev (1m)-21.26%
Revenue NQ rev (3m)-21.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-14.36%
Valuation
Industry RankSector Rank
PE 7.46
Fwd PE 14.95
P/S 1.56
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB 1.95
EV/EBITDA 19.2
EPS(TTM)1.41
EY13.4%
EPS(NY)0.7
Fwd EY6.69%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.74
BVpS8.48
TBVpS5.4
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.04%
ROE 1.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.39%
GM 48.43%
FCFM N/A
ROA(3y)-8.43%
ROA(5y)-13.77%
ROE(3y)-105.34%
ROE(5y)-141.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5Y4.68%
F-ScoreN/A
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 9.44
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.69
Quick Ratio 9.06
Altman-Z -0.22
F-ScoreN/A
WACC6.95%
ROIC/WACCN/A
Cap/Depr(3y)97.09%
Cap/Depr(5y)83.67%
Cap/Sales(3y)12.3%
Cap/Sales(5y)12.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
EPS Next Y190.92%
EPS Next 2Y-0.44%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue 1Y (TTM)4.01%
Revenue growth 3Y31.09%
Revenue growth 5Y10.9%
Sales Q2Q%2.89%
Revenue Next Year0.17%
Revenue Next 2Y10.94%
Revenue Next 3Y12.66%
Revenue Next 5YN/A
EBIT growth 1Y76.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year345.07%
EBIT Next 3Y136.88%
EBIT Next 5YN/A
FCF growth 1Y19.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.33%
OCF growth 3YN/A
OCF growth 5YN/A